Orforglipron News
Latest articles and news about Orforglipron on AXL Media.
Latest Articles
- United Arab Emirates Approves Eli Lilly Weight Loss Pill for May 2026 Launch Following Successful Clinical Trials
Published: Apr 4, 2026
Section: Middle East
The United Arab Emirates Ministry of Health and Prevention has officially registered orforglipron, an oral weight management medication developed by Eli Lilly, making the UAE the s...
- FDA Approves Eli Lilly’s Weight-Loss Pill Foundayo, Intensifying Rivalry with Novo Nordisk
Published: Apr 2, 2026
Section: Medical News
The U.S. Food and Drug Administration has granted approval to Eli Lilly’s oral weight-loss medication, orforglipron, to be marketed as Foundayo. The once-daily pill demonstrated a...
- Novel Weight Loss Pill Orforglipron Outperforms Oral Semaglutide in Blood Sugar Control and Weight Loss
Published: Feb 26, 2026
Section: Health
A Phase 3 randomized controlled trial published in The Lancet has demonstrated that orforglipron, a new oral GLP-1 receptor agonist, delivers superior reductions in blood sugar and...